394 related articles for article (PubMed ID: 21697009)
1. Melanin concentrating hormone in central hypersomnia.
Peyron C; Valentin F; Bayard S; Hanriot L; Bedetti C; Rousset B; Luppi PH; Dauvilliers Y
Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
3. Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2.
Schrölkamp M; Jennum PJ; Gammeltoft S; Holm A; Kornum BR; Knudsen S
J Clin Sleep Med; 2017 Feb; 13(2):235-243. PubMed ID: 27855741
[TBL] [Abstract][Full Text] [Related]
4. [Narcolepsy--new implications of molecular biology].
Knudsen S; Jennum PJ
Ugeskr Laeger; 2006 Oct; 168(43):3699-704. PubMed ID: 17069732
[TBL] [Abstract][Full Text] [Related]
5. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
[TBL] [Abstract][Full Text] [Related]
6. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
[TBL] [Abstract][Full Text] [Related]
7. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.
Baumann CR; Dauvilliers Y; Mignot E; Bassetti CL
Eur Neurol; 2004; 52(2):73-6. PubMed ID: 15256827
[TBL] [Abstract][Full Text] [Related]
8. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
[TBL] [Abstract][Full Text] [Related]
9. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
10. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
[TBL] [Abstract][Full Text] [Related]
11. Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation.
Kitka T; Adori C; Katai Z; Vas S; Molnar E; Papp RS; Toth ZE; Bagdy G
Neurochem Int; 2011 Oct; 59(5):686-94. PubMed ID: 21740944
[TBL] [Abstract][Full Text] [Related]
12. Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder?
Baumann C; Ferini-Strambi L; Waldvogel D; Werth E; Bassetti CL
J Neurol; 2005 Feb; 252(2):139-45. PubMed ID: 15729517
[TBL] [Abstract][Full Text] [Related]
13. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
[TBL] [Abstract][Full Text] [Related]
14. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
15. Narcolepsy in Parkinson's disease.
Haq IZ; Naidu Y; Reddy P; Chaudhuri KR
Expert Rev Neurother; 2010 Jun; 10(6):879-84. PubMed ID: 20518604
[TBL] [Abstract][Full Text] [Related]
16. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
[TBL] [Abstract][Full Text] [Related]
17. [Neurophysiological examinations in narcolepsy].
Wierzbicka A; Wichniak A; Czasak K; Musińska I; Jakubczyk T; Sek A; Jernajczyk W
Przegl Lek; 2010; 67(9):726-8. PubMed ID: 21387813
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
Compta Y; Santamaria J; Ratti L; Tolosa E; Iranzo A; Muñoz E; Valldeoriola F; Casamitjana R; Ríos J; Marti MJ
Brain; 2009 Dec; 132(Pt 12):3308-17. PubMed ID: 19858078
[TBL] [Abstract][Full Text] [Related]
19. Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma.
Tachibana N; Taniike M; Okinaga T; Ripley B; Mignot E; Nishino S
Sleep Med; 2005 Nov; 6(6):567-9. PubMed ID: 16084764
[TBL] [Abstract][Full Text] [Related]
20. Hypersomnia and low cerebrospinal fluid hypocretin levels in acute disseminated encephalomyelitis.
Yoshikawa S; Suzuki S; Kanbayashi T; Nishino S; Tamai H
Pediatr Neurol; 2004 Nov; 31(5):367-70. PubMed ID: 15519122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]